Bicalutamide, mesna, sulindac and other anti-cancer drugs
HS Code: 2930909092
SECTION 6
PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
CHAPTER 29
Organic chemicals
HEADING 2930
Organo-sulphur compounds
HS Code Structure Breakdown
| Level | Code | Description |
|---|---|---|
| Section | 6 | PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES |
| Chapter | 29 | Organic chemicals |
| Heading | 2930 | Organo-sulphur compounds |
| Subheading | 293090 | Bicalutamide, mesna, sulindac and other anti-cancer drugs |
| Commodity | 2930909092 | Bicalutamide, mesna, sulindac and other anti-cancer drugs |
HS Code 2930909092 for Bicalutamide, mesna, sulindac and other anti-cancer drugs
Product Wiki
Bicalutamide, mesna, sulindac and other anti-cancer drugs has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.
Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Bicalutamide, mesna, sulindac and other anti-cancer drugs, with its export volume maintaining a high level over the long term.
Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Bicalutamide, mesna, sulindac and other anti-cancer drugs.
With technological advancements and the diversification of market demands, the scope of application for Bicalutamide, mesna, sulindac and other anti-cancer drugs continues to expand, driving the development of related industries.
Currently, the global supply-demand balance of Bicalutamide, mesna, sulindac and other anti-cancer drugs is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.
Partner



Our licenses

China

HK MSO License

Singapore

UK API License

Netherlands

US MSB

CA MSB

AU RSP

